TYCHE INDUSTRIES LTD. Share Price

Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal and others. Its intermediates include 4-(3,4-Dichlorophenyl)-1-tetralone, 1-Benzylpiperidine-4-Carboxaldehyde (BPCA), 3-Hydroxymethyl quinuclidine Hcl, and others. Its chiral intermediates include S-(+)-3-Quinuclidinol, R-(-)-3-Quinuclidinol and others. The Company's nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.As of 18 Jun 2026, TYCHE INDUSTRIES LTD. share price is ₹132.00. The stock opened at ₹129.30, compared to its previous close of ₹128.85. During today's trading session, TYCHE INDUSTRIES LTD. share price moved in the range of ₹128.60 to ₹135.70, with an average price of ₹132.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹128.60 and a high of ₹135.70.

The market capitalization of TYCHE INDUSTRIES LTD. is ₹132 Crs, with a P/E ratio of 19.0 and a dividend yield of 2.72%.